Standard BioTools Inc (NAS:LAB)
$ 2.05 -0.06 (-2.84%) Market Cap: 758.34 Mil Enterprise Value: 387.95 Mil PE Ratio: 0 PB Ratio: 1.35 GF Score: 72/100

Q3 2022 Standard BioTools Inc Earnings Call Transcript

Nov 08, 2022 / 10:00PM GMT
Release Date Price: $0.9804 (-2.93%)
Operator

Hello, and welcome to the Standard BioTools Inc. Third Quarter 2022 Financial Results Conference Call. As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host, Peter DeNardo, Investor Relations. Thank you, Mr. DeNardo. You may begin.

Peter DeNardo
Standard BioTools Inc. - IR

Thank you, operator. Good afternoon, everyone. Welcome to Standard BioTools Third Quarter 2022 Earnings Conference Call. At the close of the market today, Standard BioTools released its financial results for the quarter ended September 30, 2022.

During this call, we will review our results and provide commentary on our financial and operational performance, market trends and strategic initiatives. Presenting for Standard BioTools today will be Michael Egholm PhD, Chief Executive Officer and President; and Vikram Jog, our CFO.

During the call, we will make forward-looking statements about events and circumstances that have not yet occurred, including plans and projections for our business, future financial results and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot